488 related articles for article (PubMed ID: 18313521)
1. Clinical outcome analysis in "high-risk" versus "low-risk" patients eligible for national surgical adjuvant breast and bowel B-39/radiation therapy oncology group 0413 trial: five-year results.
Patel RR; Christensen ME; Hodge CW; Adkison JB; Das RK
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):970-3. PubMed ID: 18313521
[TBL] [Abstract][Full Text] [Related]
2. Five-year results: the initial clinical trial of MammoSite balloon brachytherapy for partial breast irradiation in early-stage breast cancer.
Benitez PR; Keisch ME; Vicini F; Stolier A; Scroggins T; Walker A; White J; Hedberg P; Hebert M; Arthur D; Zannis V; Quiet C; Streeter O; Silverstein M
Am J Surg; 2007 Oct; 194(4):456-62. PubMed ID: 17826055
[TBL] [Abstract][Full Text] [Related]
3. Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy.
Wazer DE; Kaufman S; Cuttino L; DiPetrillo T; Arthur DW
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):489-95. PubMed ID: 16246495
[TBL] [Abstract][Full Text] [Related]
4. High-dose-rate brachytherapy alone versus whole breast radiotherapy with or without tumor bed boost after breast-conserving surgery: seven-year results of a comparative study.
Polgár C; Major T; Fodor J; Németh G; Orosz Z; Sulyok Z; Udvarhelyi N; Somogyi A; Takácsi-Nagy Z; Lövey K; Agoston P; Kásler M
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1173-81. PubMed ID: 15519789
[TBL] [Abstract][Full Text] [Related]
5. Breast-conserving treatment with partial or whole breast irradiation for low-risk invasive breast carcinoma--5-year results of a randomized trial.
Polgár C; Fodor J; Major T; Németh G; Lövey K; Orosz Z; Sulyok Z; Takácsi-Nagy Z; Kásler M
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):694-702. PubMed ID: 17531400
[TBL] [Abstract][Full Text] [Related]
6. Acute complications of MammoSite brachytherapy: a single institution's initial clinical experience.
Harper JL; Jenrette JM; Vanek KN; Aguero EG; Gillanders WE
Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):169-74. PubMed ID: 15629608
[TBL] [Abstract][Full Text] [Related]
7. Accelerated partial breast irradiation with iridium-192 multicatheter PDR/HDR brachytherapy. Preliminary results of the German-Austrian multicenter trial.
Ott OJ; Pötter R; Hammer J; Hildebrandt G; Lotter M; Resch A; Pöhls U; Beckmann MW; Sauer R; Strnad V
Strahlenther Onkol; 2004 Oct; 180(10):642-9. PubMed ID: 15480513
[TBL] [Abstract][Full Text] [Related]
8. Preliminary results and evaluation of MammoSite balloon brachytherapy for partial breast irradiation for pure ductal carcinoma in situ: a phase II clinical study.
Benitez PR; Streeter O; Vicini F; Mehta V; Quiet C; Kuske R; Hayes MK; Arthur D; Kuerer H; Freedman G; Keisch M; Dipetrillo T; Khan D; Hudes R
Am J Surg; 2006 Oct; 192(4):427-33. PubMed ID: 16978943
[TBL] [Abstract][Full Text] [Related]
9. Long-term cosmesis after lumpectomy and brachytherapy in the management of carcinoma of the previously irradiated breast.
Trombetta M; Julian TB; Werts DE; McWilliams W; Kim Y; Miften M; Parda D
Am J Clin Oncol; 2009 Jun; 32(3):314-8. PubMed ID: 19451803
[TBL] [Abstract][Full Text] [Related]
10. Early breast cancer treated with conservative surgery, adjuvant chemotherapy, and delayed accelerated partial breast irradiation with high-dose-rate brachytherapy.
Gómez-Iturriaga A; Pina L; Cambeiro M; Martínez-Regueira F; Aramendía JM; Fernández-Hidalgo O; Martínez-Monge R
Brachytherapy; 2008; 7(4):310-5. PubMed ID: 18778971
[TBL] [Abstract][Full Text] [Related]
11. Breast conservation surgery and interstitial brachytherapy in the management of locally recurrent carcinoma of the breast: the Allegheny General Hospital experience.
Trombetta M; Julian T; Bhandari T; Werts ED; Miften M; Parda D
Brachytherapy; 2008; 7(1):29-36. PubMed ID: 18201940
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcome and toxicity in a Phase I/II trial using high-dose-rate multicatheter interstitial brachytherapy for T1/T2 breast cancer.
Kaufman SA; DiPetrillo TA; Price LL; Midle JB; Wazer DE
Brachytherapy; 2007; 6(4):286-92. PubMed ID: 17991625
[TBL] [Abstract][Full Text] [Related]
13. Early European experience with the MammoSite radiation therapy system for partial breast brachytherapy following breast conservation operation in low-risk breast cancer.
Niehoff P; Ballardini B; Polgár C; Major T; Hammer J; Richetti A; Kovács G
Breast; 2006 Jun; 15(3):319-25. PubMed ID: 16765284
[TBL] [Abstract][Full Text] [Related]
14. The incidence of lung carcinoma after surgery for breast carcinoma with and without postoperative radiotherapy. Results of National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trials B-04 and B-06.
Deutsch M; Land SR; Begovic M; Wieand HS; Wolmark N; Fisher B
Cancer; 2003 Oct; 98(7):1362-8. PubMed ID: 14508821
[TBL] [Abstract][Full Text] [Related]
15. Differences in patterns of failure in patients treated with accelerated partial breast irradiation versus whole-breast irradiation: a matched-pair analysis with 10-year follow-up.
Antonucci JV; Wallace M; Goldstein NS; Kestin L; Chen P; Benitez P; Dekhne N; Martinez A; Vicini F
Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):447-52. PubMed ID: 19058921
[TBL] [Abstract][Full Text] [Related]
16. [Evidence-based radiotherapy in the treatment of operable breast cancer: results in the 1990-ies].
Fodor J; Polgár C; Németh G
Orv Hetil; 2000 Jul; 141(28):1551-5. PubMed ID: 10957865
[TBL] [Abstract][Full Text] [Related]
17. The feasibility of a second lumpectomy and breast brachytherapy for localized cancer in a breast previously treated with lumpectomy and radiation therapy for breast cancer.
Chadha M; Feldman S; Boolbol S; Wang L; Harrison LB
Brachytherapy; 2008; 7(1):22-8. PubMed ID: 18299110
[TBL] [Abstract][Full Text] [Related]
18. Three-year results of treatment for prostate cancer with low-dose rate temporary iridium-192 brachytherapy.
Momma T; Saito S; Toya K; Yorozu A; Dokiya T; Murai M
Int J Urol; 2006 Mar; 13(3):218-23. PubMed ID: 16643612
[TBL] [Abstract][Full Text] [Related]
19. Phase II trial of brachytherapy alone after lumpectomy for select breast cancer: toxicity analysis of RTOG 95-17.
Kuske RR; Winter K; Arthur DW; Bolton J; Rabinovitch R; White J; Hanson W; Wilenzick RM
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):45-51. PubMed ID: 16503383
[TBL] [Abstract][Full Text] [Related]
20. Electron and high-dose-rate brachytherapy boost in the conservative treatment of stage I-II breast cancer first results of the randomized Budapest boost trial.
Polgár C; Fodor J; Orosz Z; Major T; Takácsi-Nagy Z; Mangel LC; Sulyok Z; Somogyi A; Kásler M; Németh G
Strahlenther Onkol; 2002 Nov; 178(11):615-23. PubMed ID: 12426672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
